Alcobra ADHD 深 沪
等待开盘 10-30 09:30:00 美东时间
1.46
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 1.46
- 总市值 4024.00万
- 52周最高 2.577
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.83
- 委 比 0.00%
- 总股本 2756.16万
- 历史最高 26.96
- 量 比 0
- 振 幅 0.00%
- 历史最低 0.83
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Supernus a new buy at BofA on 'underappreciated' CNS assets
BofA Securities has initiated coverage of Supernus Pharmaceuticals (SUPN) at buy saying that the market is not fully appreciating the company's portfolio of central nervous system drugs. The bank set ...
今天 02:37
华尔街顶级分析师最新评级报告：联合健康遭下调
华尔街最受关注、且能影响市场走势的研究评级报告现已汇总于此。以下是由 The Fly 整理的今日投资者需重点关注的评级信息。 五大评级上调案例 思佳讯...
10-29 22:12
Ken Paxton Alleges Johnson & Johnson Misled Mothers On Tylenol Safety
Texas Attorney General Ken Paxton sued Johnson & Johnson and Kenvue, alleging Tylenol was deceptively marketed as safe for pregnant women.
10-29 01:11
脑再生科技区一佳440亿身家首登《胡润百富榜》，而公司至今尚未盈利
炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 10月28日，胡润研究院发布《2025衡昌烧坊·胡润百富榜》，脑再生科技C...
10-28 20:26
Deep Dive Into Supernus Pharmaceuticals Stock: Analyst Perspectives (5 Ratings)
Ratings for Supernus Pharmaceuticals (NASDAQ:SUPN) were provided by 5 analysts ...
10-24 05:02
Cingulate's Data From Lead ADHD Candidate CTx-1301 Selected For Podium Presentation At AACAP Annual Meeting In Chicago
Cingulate Inc. (NASDAQ:CING), a biopharmaceutical company developing and advancing a pipeline of next-generation pharmaceutical products utilizing its proprietary Precision Timed Release™ (PTR™)
10-24 04:48
伟思医疗：前三季度营收净利双增 净利增长30.68%
10月22日晚，南京伟思医疗科技股份有限公司（股票代码：688580，以下简称“伟思医疗”）发布了2025年第三季度报告，展现了公司稳健的经营韧性与增长动力。
10-22 20:24
Cingulate Announces That U.S. FDA Accepts For Review Its New Drug Application For CTx-1301, Its Lead ADHD Treatment Candidate For Children And Adults
Cingulate Inc. (NASDAQ:CING) a biopharmaceutical company developing and advancing a pipeline of next-generation pharmaceutical products utilizing its proprietary Precision Timed Release™ (PTR™)
10-14 20:02
Tylenol Turmoil: Partisan Politics Fuel Confusion Over Pregnancy Risks, Poll Shows
KFF poll shows falling trust in the CDC and HHS chief RFK Jr. as misinformation and partisan divides shape public views on vaccines.
10-11 01:24
Vivos' Study Demonstrates Its Daytime-Nighttime Appliance Provides Relief, Quality Of Life Improvement In Children With Attention-Deficit/Hyperactivity Disorder, Obstructive Sleep Apnea
Previously Unpublished Data Confirms Vivos DNA Devices Offer a Safe and Effective Alternative Treatment for Children with ADHD and Obstructive Sleep Apnea LITTLETON, Colo., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Vivos
09-30 20:41
